J. Suker

发表

The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation

M. Achtman, M. Maiden, G. Morelli, 1994, Molecular microbiology.

Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis

M. Maiden, J. Bygraves, I. Feavers, 1991, Molecular microbiology.

Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.

M. Maiden, I. Feavers, J. Suker, 1996, Microbiology.

Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254

I. Feavers, J. Wheeler, Christopher Jones, 2006, Proteomics.

Application of Optical Biosensor Techniques to the Characterization of PorA-Antibody Binding Kinetics.

B. Charalambous, J. Suker, 2001, Methods in molecular medicine.

Structural analysis of the variation in the major outer membrane proteins of Neisseria meningitidis and related species.

M. Maiden, I. Feavers, J. Suker, 1993, Biochemical Society transactions.

Molecular analysis of the serotyping antigens of Neisseria meningitidis

A. Heath, M. Maiden, I. Feavers, 1992, Infection and immunity.

Some unusual manifestations of parathyroid disease.

J. Suker, J. R. Hines, 1973, The Surgical clinics of North America.

Control and lot release of meningococcal group C conjugate vaccines

I. Feavers, M. Corbel, Christopher Jones, 2004, Expert review of vaccines.

Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254

I. Feavers, J. Wheeler, Christopher Jones, 2006 .

Characterisation of the Protein Content of a Meningococcal Outer Membrane Vesicle Vaccine by Polyacrylamide Gel Electrophoresis and Mass Spectrometry

I. Feavers, J. Wheeler, Christopher Jones, 2005 .

Structural and Evolutionary Inference from Molecular Variation in Neisseria Porins

J. Derrick, M. Maiden, R. Urwin, 1999, Infection and Immunity.

Prospects offered by genome studies for combating meningococcal disease by vaccination.

I. Feavers, J. Suker, 2001, Pharmacogenomics.

Neisseria meningitidis Subtype Nomenclature

M. Maiden, J. Russell, I. Feavers, 1999, Clinical Diagnostic Laboratory Immunology.

PorA Variable Regions of Neisseria meningitidis

Keith A. Jolley, Joanne E. Russell, K. Jolley, 2004, Emerging infectious diseases.

Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry.

I. Feavers, J. Wheeler, Christopher Jones, 2005, Human vaccines.